Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:50:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record page no longer shows the 403 Forbidden error content, removing the previously displayed error state.
    Difference
    0.5%
    Check dated 2026-09-27T22:09:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study content with an error page. This blocks access to trial details and related navigation, affecting a user’s ability to review the record.
    Difference
    18%
    Check dated 2026-09-20T20:03:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, signaling a minor update to the page metadata/content. This change does not alter the study details or results information.
    Difference
    0.1%
    Check dated 2026-08-30T21:54:01.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a small version update to the page. It does not change study content, eligibility criteria, or results; it is a background maintenance update.
    Difference
    0.1%
    Check dated 2026-08-09T09:27:20.000Z thumbnail image

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.